Explore the relationship between serum amino acids and diabetic peripheral neuropathy

Detect the serum biomarkers of DPN based on H-NMR

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400088659

Enrollment

Unknown

Registered

2024-08-23

Start date

2022-10-11

Completion date

Unknown

Last updated

2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic peripheral neuropathy

Interventions

diabetic peripheral neuropathy:none

type 2 diabetes mellitus:none

normal control:none

Eligibility

Sex/Gender

All

Age

18 Years to 95 Years

Inclusion criteria

Inclusion criteria: 1.Age> 18 years, being able and willing to cooperate with specimen collection; 2.Type 2 diabetes mellitus was diagnosed according to the American Diabetes Association criteria in 2019; 3.EMG suggesting multiple peripheral neuropathy, patients having associated symptoms, and meeting the MNSI and TCSS scoring table criteria 4.Both parties signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Coronary heart disease, cerebral infarction, and malignant tumor; 2. Liver and kidney insufficiency; 3. Other endocrine diseases such as hyperthyroidism; 4. Take drugs that affect the peripheral nerves; 5. Long-term history of alcohol drinking and smoking; 6. Infectious diseases such as tuberculosis and viral hepatitis.

Design outcomes

Primary

Measure	Time frame
serum amino acids;	—

Secondary

Measure	Time frame
basic clinical indicators;	—

Countries

China

Contacts

Public ContactFuqing Lin

Shanghai Tenth People’s Hospital

fuqinglin@tongji.edu.cn+86 189 1768 4132

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026